Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma.
- DOI
- 10.2147/ott.s117743
- Published
- 2016
- Container
- OncoTargets and therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2147/ott.s117743,
title = {Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma.},
author = {Jeannot V and Busser B and Vanwonterghem L and Michallet S and Ferroudj S and Cokol M and Coll JL and Ozturk M and Hurbin A},
year = {2016},
journal = {OncoTargets and therapy},
doi = {10.2147/ott.s117743},
url = {https://doi.org/10.2147/ott.s117743}
}RIS
TY - JOUR TI - Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma. AU - Jeannot V AU - Busser B AU - Vanwonterghem L AU - Michallet S AU - Ferroudj S AU - Cokol M AU - Coll JL AU - Ozturk M AU - Hurbin A PY - 2016 JO - OncoTargets and therapy DO - 10.2147/ott.s117743 UR - https://doi.org/10.2147/ott.s117743 ER -
APA
V, J., B, B., L, V., S, M., S, F., M, C., JL, C., M, O., & A, H. (2016). Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma.. OncoTargets and therapy. https://doi.org/10.2147/ott.s117743
Source records
- pubmed · retrieved 2026-09-27T09:49:17.825Z